Colossal Biosciences
$3.53B
$120M
Latest RoundSeries C+
$10.3B
Latest Funding DateSep 18, 2025
About Colossal Biosciences
Colossal Biosciences is a biotechnology company working on 'de-extinction,' using gene editing to bring back species like the woolly mammoth and dodo while building conservation tech for endangered animals.
Funding Rounds
| Round | |||
|---|---|---|---|
| Sep 18, 2025 | Series C+ | $120M | $10.3B |
| Sep 17, 2025 | Series C | $320M | $10.32B |
| Jan 15, 2025 | Series C | $301.16M | $10.2B |
| Feb 3, 2023 | Series B | $173.8M | $1B |
| Mar 9, 2022 | Series A | $65.43M | - |
| May 1, 2021 | Seed-1 | $9.02M | - |
Perpetual Markets
No perpetual markets available.
Token Issuers
No token issuer markets available.
Valuation and funding data updated Aug 25, 2026, 12:24 PM UTC.
Market data updated Aug 25, 2026, 12:24 PM UTC.